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Abstract 
In this report we review the current knowledge 
on the involvement of the interferon (IFN) system in 
the regulation of cell growth and differentiation. We 
also summarize our own data which provide evidence 
for the strong correlation between IFN-mediated 
growth-arrest of transformed cells and the elevated 
enzymatic activity of an IFN - induced protein. Simi-
larly, it is demonstrated that elevated levels of IF N-
induced proteins accompany the early phases of in -
vitro cell differentiation. IFN - treatment of NIH/ 3T3 
mouse fibroblasts transformed by Moloney-murine 
sarcoma virus ( MSV) resulted in a significant reduc -
tion in the rates of cell growth, protein synthesis 
and cloning efficiency. In parallel, 2-5A-synthetase 
activity was induced ten- fold above the background 
level. Treatment of these cells for 3 days with 450 
international units ( lU) / ml of IF N followed by its 
removal, resulted in a gradual increase in all para-
meters associated with cell growth while the 2-5A-
synthetase activity was reduced to its normal level. 
However, almost no recovery occurred when cells 
were treated with 1,800 IU/ml. In parallel, 2-5A-
synthetase activity remained highly elevated even at 
3 days after the removal of IFN. In these cells, the 
expression of both c-myc and v-mos was reduced 
rapidly following IFN treatment. Upon removal of 
IFN after 24 h of treatment, the expression of both 
genes was resumed but with a different kinetics, 
suggesting that different mechanisms are responsible 
for the reduction in gene expression. In rat skeletal 
muscle cultures which differentiate to form myotubes, 
the level of both 2-5A-synthetase and protein kinase 
activities was transiently elevated, reaching a peak 
at 3 days followed by a decrease to background 
levels. This peak activity precedes the appearance 
of the major muscle differentiating proteins. 
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Introduction 
Interferon (IFN) is now well known as a gener-
al regulatory molecule which participates in a variety 
of biological processes within an organism. Increas-
ing evidence suggests that one of the most important 
functions of IFN regulation concerns the growth and 
differentiation of different cell systems [Clemens, 
McNurlan, 1985; Moritz, Kirchner , 1986]. It has been 
established that the progression of the cell from the 
stationary phase (G0 ) through the cell cycle is 
associated with the activation of certain genes [ Kelly 
et al., 1983; Cochran et al., 1984 ; Greenberg, Ziff, 
1984; Bravo et al., 1985]. On the other hand, cell 
differentiation is accompanied in many cases by the 
repression of gene expression [Westin et al., 1982; 
Einat et al., 1985]. The possible involvement of IFN 
in the regulation of gene expression is not clear, but 
it has been demonstrated that in some hematopoietic 
cell systems, IFN is produced in an autocrine manner 
following induction of differentiation and one of the 
major IFN-induced proteins - ( 2 '-5 ' )oligoadenylate 
synthetase (2-5A-synthetase), is induce during the 
process [Kimchi, 1981; Friedman-Einat et al., 1982; 
Yarden et al., 1984; Resnitzky et al., 1986]. The 
induction is abolished when the cells are incubated 
with antibodies directed against beta-IFN [Kimchi, 
1981; Friedman-Einat et al., 1982]. Moreover, 2-5A-
synthetase gene expression is induced in quiescent 
cells stimulated to grow with a variety of growth 
factors [ Lin et al., 1983; Wells, Mallucci, 1985; Zulla 
etal., 1985; Garcia-Blanco et al., 1989]. In addition, 
IFN has been shown to inhibit the expression of cer-
tain oncogenes, c-myc in particular, in some treated 
cells [Jonak, Knight, 1984; Einat et al., 1985; 
Emanoil-Ravier et al., 1985]. Thus, it is tempting to 
postulate that at least some of the regulatory func -
tions attributed to IFN is mediated through IFN-in-
duced enzymes, generally referred to as the IFN sys-
tem, such as 2-5A-synthetase, 2-5A activated RNase 
[Jacobsen et al., 1983; Krause et al., 1985], and the 
double-stranded activated protein kinase [ Galabru, 
Hovanessian, 1985]. The first catalyzes the synthesis 
of oligomers of adenylic acid in the 2' -5' phosphodi-
ester bond [Kerr, Brown, 1978] which activates a la-
tent endonuclease responsible for the degradation of 
messenger and ribosomal RNA molecules [Williams et 
al., 197 8; Hovanessian et al., 1979; Wreschner et al., 
1981]. Activation of the 2-5A system and protein 
kinase may, therefore, directly cause inhibition of 
protein synthesis [Kerr, Brown, 1978; Williams et al., 
1978] as manifested by antiproliferative effects. 
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Indeed, IFN has been shown to inhibit the growth of 
murine sarcoma virus ( MSV)-transformed cells 
[Bakhanashvili et al., 1983]. In addition, it causes 
the reversion of the transformed phenotype of cells 
transformed by retroviruses [ Hicks et al., 1981] or by 
an activated oncogene [ Sam id et al., 1984] . It has 
also been demonstrated that 2-5A-synthetase activity 
is induced to a much greater level in the trans-
formed cells than in their normal counterpart 
[Bakhanashvili et al., 1983; David et al., 1989]. 
Furthermore, the activity of both enzymes appears to 
correlate in certain cases with both the antiviral and 
the antiproliferative effects of IFN [Bakhanashvili et 
al., 1983; Samuel et al., 1984; Rice et al., 1985; 
Resnitzky et al., 1986; Chebath et al., 1987b]. It is, 
thus, obvious that in order to elucidate the role of 
IFN in the regulation of growth and differentiation, 
the involvement of the IFN system in these processes 
should be demonstrated and studied. 
Skeletal muscle cultures provide a unique system 
for the study of morphological and biochemical dif-
ferentiation. Primary myoblasts can be prepared 
from the embryonic tissues of a variety of species. 
With time in culture, the myoblasts fuse to form 
multinucleated myotubes which later contract sponta-
neously, a characteristic of differentiated muscle 
fibers. This event is accompanied by the synthesis 
of muscle-specific proteins, increase in acetyl-
cholinesterase activity, the appearance of acetyl-
choline receptor molecules [Fambrough, Rash, 1971; 
Shainberg et al., 1984; Buckingham, 1977; Shainberg, 
Brik, 1978], and a decrease in DNA polymerase 
activity and in DNA synthesis. 
The demonstration that the IFN system is acti-
vated during the process of muscle differentiation as 
well as during the arrest of tumor cell growth is es -
sential for understanding the role of the system in 
the regulation of basic physiological processes within 
the organism. Our data provide evidence for these 
phenomena and is presented as part of an overview 
on the involvement of the IFN system in cell growth 
and differentiation as discussed at the Scanning 
Microscopy meetings during May 1989 at Salt Lake 
City, Utah. 
Materials and Methods 
Cell cultures 
N 1H / 3T 3 mouse fibroblasts transformed by and 
producing the Moloney strains of MSV and murine 
leukemia virus (strain 124) [NIH/3T3(MSV) cells] 
were used throughout this study. Occasionally, we 
also used the TB cell line (clone 124) producing the 
same viral complex [Ball et al., 1973] with identical 
results. The cells were maintained in Dulbecco's 
modified Eagle medium supplemented with 10% new-
born calf serum (Biological Industries, Beit Haemek, 
Israel). The cultures were subdivided every 3-4 days 
into 9 cm tissue culture dishes (Nunc, Roskilde, Den-
mark) and kept at 37°C in a humidified incubator 
flushed with 10% CO2. Rat skeletal muscle cultures 
were prepared essentially as previously described 
[Shainberg et al., 1984]. In all experiments with 
IFN, the serum concentration was reduced to 2 .5 % .
Interferon 
Mouse beta interferon was used in this study. 
It was supplied by Lee Biomolecular ( San Diego, CA) 
with a specific activity of 5 .6x107 international units 
(IU) per mg protein (cat. No. 20171). 
Determination of growth rate 
About 5xlo4 cells were seeded in 3 .5 cm tissue 
culture dishes ( Nunc, Roskilde, Denmark). A few 
hours after seeding, when the cells were attached to 
the dish, the medium was replaced with fresh medium 
containing various concentrations of IFN. At the in-
dicated times after treatment, the cells were removed 
by trypsin, stained with 0.5% trypan blue (in PBS) 
and the number of viable cells was determined. 
Determination of the rate of protein synthesis 
Cells were seeded and treated with IFN as 
described above. At the indicated times after 
treatment, the medium was removed and 1 ml/ dish of 
fresh medium (containing no serum) supplemented 
with 0.25 micro-Ci of -:ltt-leucine (130 Ci/mmol; 
Amersham International, Amersham, UK) was added. 
After incubation for 3 h at 37°C, the medium was 
removed, cultures were washed 3 times with cold 
PBS, and the cells were lysed with 1 ml of O .5% 
sodium dodecyl sulfate. Acid-insoluble material was 
precipitated with 10 % cold trichloroacetic acid and 
the precipitate was collected on glass-fiber filters. 
The filters were dried, immersed in a toluene-based 
scintillation liquid and counted. 
Determination of cloning efficiency 
The cultures were treated with IFN as described 
above. At the indicated times after treatment, cells 
were removed, counted and reseeded in 5 cm dishes 
at 100 cells per dish in IFN-free medium. After 10-
14 days, the cultures were fixed with methanol, 
stained with Giemsa stain and the number of clones 
was determined. 
Recovery from the IFN effect 
Cultures were treated with the indicated IFN 
concentration, as described above, for 72 h. The 
cells were then removed with trypsin, washed 4 times 
with PBS, reseeded at 5xlo4 cells per 3 .5 cm dish or 
at 5x105 cells per 10 cm dish (for the determination 
of 2-5A-synthetase activity), and subdivided into two 
groups. One group received IF N-free medium, while 
the other received medium containing identical con-
centrations of IFN used during the first 72 h. All 
parameters were then determined as described above. 
Preparation of cell extracts (SlO) 
Cell extracts were prepared after the appropri-
ate treatment by removing the cultured cells with a 
rubber policeman in PBS. The cells were then cen-
trifuged at 800x g for 5 min, washed twice with cold 
PBS and resuspended for 10 min in an ice-cold lysis 
buffer (buffer A) containing 20mM Hepes pH 7.5, 
5mM Mg-Acetate, 0 .5 % NP-40, lmM dithiothreitol, 
10% glycerol and 1 mM EDTA. The extracts were 
centrifuged at 10,000x g for 10 min and the soluble 
fractions (SlO) were stored at -70°C until use. 
Determination of 2-5A synthetase activity 
The activity of 2-5A -synthetase in cell extracts 
(SlO) was performed as previously described [Chebath 
et al., 1987a] with 20 microgram protein in the pres-
ence of 50 microgram/ml of poly(!) .poly(C) (Pharma-
cia, Uppsala, Sweden). In some cases, the extracts 
were first incubated with poly(!) .poly(C) agarose 
beads (Pharmacia), washed and then assayed for 2-
5A-synthetase activity. The same results were ob-
tained. Hence, the "in solution" method was routine -
ly used. The 32P-labeled 2-5A oligomers were ana-
lyzed by high voltage electrophoresis [ Chebath et al., 
1987a]. The radioactive spots were detected by 
autoradiography and the amount of radioactivity in 
each spot was determined by immersing the dried 
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spots in toluene-based scintillation fluid. The results 
are presented as pmoles of ATP polymerized based on 
the radioactivity obtained with a known amount of 
a- 32p-ATP placed on 3mm paper discs. 
Two methods were used for the size determina-
tion of 2-5A oligomers formed in the enzymatic 
assay. First, a mixture of 0 .05 units of authentic 
core forms of 2-5A dimers, trimers and tetramers 
(Pharmacia) were analyzed in parallel in each experi-
ment and the spots identified by illumination with a 
UVSL-25 lamp. In addition, we always used as a 
positive control cell extracts prepared from IFN-
treated NIH/3T3 (MSV) cells. Such extracts contain 
a high level of active 2-5A synthetase which yields 
whole series of oligomers. 
Determination of protein kinase activity 
Cell extracts (Sl0) were prepared as described 
above. Heparin (50-100 units/ml) was added to cell 
extract samples each containing 500 microgram of 
protein. The mixtures were incubated at 4°C for 10 
min. An equal volume of poly( I) .poly(C)-Sepharose 
beads (Pharmacia) was added at room temperature for 
30 min with occasional gentle mixing. The beads 
were washed several times with buffer B containing 
10 mM Hepes pH 7 .6, 50 mM KCl, 2 mM Mg-acetate, 
7 mM 2-B-mercaptoethanol, 20% glycerol, and then 
one in buffer C (buffer B supplemented with 5 mM 
MnCl2). The final pellet was resuspended in buffer 
C supplemented with 1 micro-Ci y_32P-ATP (50-100 
Ci/mmol; New England Nuclear, Boston, MA) and in-
cubated for 90 min at 30°C. After centrifugation, 
the pellet was washed 3 times with buffer C and 
resuspended in 2 / 3 volume of buffer C and 1 / 3 vol-
ume of electrophoresis sample buffer containing 6 % 
SDS (w/v), 30% glycerol (v/v), 0.02% bromophenol 
blue (w /v), 200 mM Tris-HCl, pH 6.8 and 250 mM B-
mercaptoethanol. The samples were then heated at 
95°C for 5 min and centrifuged. The supernatants 
were collected and analyzed on 10% polyacrylamide 
slab gels containing SDS. The phosphorylated pro-
teins were detected by autoradiography on Kodak 
XAR-5 film. 
DNA probes 
The probe for c-myc was a 2.9 kbp BamHI frag-
ment that contained the gag and myc specific se-
quence of the MC29 viral genome subcloned in 
pBR322 [Reddy et al., 1983). The insert DNA was 
cleaved by BamHI under conditions recommended by 
the manufacturer (New England Biolabs, Beverly, MA) 
and purified by agarose gel electrophoresis, electro-
elution, and further purification on Elutip-D columns 
(Schleicher and Schull, Dassel, W. Germany). The 
probe for detecting v-mos transcripts was a 2 .5 kbp 
EcoRI fragment of human DNA which shares a 0 .65 
kbp region of continuous homology with v-mos. This 
fragment was also cloned in pBR322 [Prakash et al., 
1982). The insert was cleaved by EcoRI and purified 
as mentioned above. All the probes were nick-
translated as previously described [Rigby et al., 1977) 
to a specific activity of lx108 cpm/microgram using 
32P-dCTP (specific activity - 800 Ci/mmol; New Eng-
land Nuclear, Boston, MA) as the labeled precursor. 
RNA preparations and hybridization 
Total RNA from confluent cultures, either un-
treated or treated with IFN as indicated for each 
experiment, was purified by LiCl-urea precipitation 
and phenole -c hloroform extraction as previously de-
scribed [Auffray, Rougeon, 1980). Poly (A)+-contain-
ing molecules were isolated by passing the RNA 
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preparation through oligo(dT) -c ellulose columns 
[Maniatis et al., 1982). For slot-blot analysis, 
samples containing the appropriate amounts of 
poly (A)+ RNA were diluted in 15xSCC (lxSSC = 0.lM 
NaCl; 0.0lM Na citrate), heated at 65°C for 15 min 
and applied to nitrocellulose membrane filters 
(Schleicher and Schuell) presoaked in l0xSSC. The 
filters were washed with 2xSSC, dried and baked at 
80°C for 2 h in a vacuum. 
For hybridization, the nitrocellulose filters were 
first prehybridized overnight at 42°C in a solution 
containing 50% formamide, 5xSSC, 0.1% SDS, 2 .25 mM 
Na4P2O7.l0H2O, 5xDenhart's (lxDenhart's = 0.02% 
Ficoll, 0.02% polyvinyl pyrrolidone, 0.02% bovine 
serum albumin) and 250 microgram/ml of denatured 
salmon sperm DNA. Hybridization was performed at 
42°C for 24 h in the same buffer containing lx106 
cpm /ml of 32p -labeled probe. 
Results 
Susceptibility of NIH/3T3(MSV) cells to growth 
mh1b1tion by IFN 
NIH/3T3(MSV) cells are highly susceptible to 
growth inhibition by IFN [ Bakhanashvili et al., 1983). 
Furthermore, in these cells, both the expression and 
activity of 2 -5A-synthetase are induced to a signifi-
cant level following IFN-treatment [Bakhanashvili et 
al., 1983; David et al., 1989) . We therefore reasoned 
that these cells may serve as a useful model for 
studies on the involvement of the IFN system in the 
regulation of cell growth. A typical result of the 
effect of mouse beta-lFN on the growth characteris-
tics of NIH/3T3(MSV) cells is shown in Fig. 1. In 
agreement with our earlier findings [ Bakhanashvili et 
al., 1983), it is clearly demonstrated that a signifi-
cant inhibition of growth in a dose dependent man-
ner is observed in our experimental system. These 
cells were thus used for further analysis. 
IF N -induced antiproliferative and 2-5A-synthetase 
activ1ties 
Smee we are attempting to establish the in-
volvement of the IFN system in the manifestation of 
the antiproliferative property of IFN, it was of in-
terest to follow the kinetics of both the growth and 
the 2-5A-synthetase activity after removal of IFN 
from the culture medium of NIH/3T3(MSV) cells. It 
is argued that as long as the enzymatic activity re-
mains elevated, the cells will continue to exhibit 
growth arrest. 
Transformed cultures were, therefore, treated 
with IFN at various concentrations for 72 h. The 
cells were then removed, replated and divided into 
two groups. One group received IFN at the same 
concentrations while the other was refed with IFN-
free medium. The rates of cell growth and protein 
synthesis were then determined. As illustrated in 
Fig. 2, treatment with IFN at low concentrations 
(90-450 IU/ml) for 72 h resulted in almost full re-
covery of the treated cells following removal of IFN. 
However, as the IFN concentration increased, the 
recovery was less evident and at 1200-1800 IU/ml, 
there was almost no recovery, with the kinetics of 
both cell growth and protein synthesis identical in 
continuously IFN-treated cultures and in cultures 
treated with IFN for 72 h only. 
Similar conclusions can be drawn from the re-
sults on the cloning efficiency of treated cultures 
summarized in Fig. 3. The cloning efficiency of cells 
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Figure 1: Phase contrast micrographs of effect of IFN on NIH/3T 3 (MSV) cultures. (A) Control untreated 
cultures. Cultures were treated for 3 days with IFN at the following concentrations: (B) 400IU /ml; (C) 
800IU /ml; and (D) 1, 200IU /ml. 
treated for 72 h with IFN at 1800 IU / ml and grown 
further in IFN - free medium for another 72 h was 
close to that of cells continuously treated with IFN. 
However, since all cells were cloned in the absence 
of IFN, partial recovery was detected even in cul-
tures treated for the first 72 h with 1200 IU/ml of 
IFN. Furthermore, it appeared that the fraction of 
cells among the entire cell population capable of 
producing clones remained stable after 72 h treat-
ment with IFN, even when the cultures were treated 
with IFN for an additional 72 h. 
It should be emphasized that in several experi-
ments cultures were treated continuously with IFN 
for 96 h without being subdivided. Here again, max -
imum activity was seen at 72 h after treatment, and 
the same level of inhibition was observed at 96 h 
(unpublished data). However, the cells tended to de-
tach from the plate's surface as incubation proceed-
ed. Therefore, the subdivision procedure described 
above was used in most experiments. 
Next, the kinetics of 2-5A-synthetase activity 
was determined under similar experimental conditions. 
Cells were treated with either 450 or 1800 IU/ml of 
IFN for 72 h, then subdivided into two sets. One 
set received IFN at the same concentration, and the 
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other was fed with IFN - free medium. The activity 
of 2-5A-synthetase was determined at daily intervals 
thereafter. The results shown in Fig. 4 clearly dem -
onstrate that the enzymatic activity in continuously 
treated cultures remained high throughout the entire 
incubation period in both IFN concentrations used. 
However, in cells treated with IFN for only 3 days, 
the level of 2-5A activity was reduced to its normal 
level following treatment with 450 IU/ml, where the 
level of the enzymatic activity remains high , al -
though IFN is no longer present in the culture medi -
um. These results correlate well with the data on 
the recovery from the IF N -induced antiproliferative 
effect described above (see Fig. 2). 
The IF N effect and oncogene expression 
The protooncogene c -myc is a cell cycle associ-
ated gene shown to be expressed during stimulated 
cell growth [Kelly et al., 1983] and, when constitu-
tively activated, to block cell differentiation 
[Coppola, Cole, 1986; Dmitrovsky et al., 1986; 
Freytag, 1988]. The viral oncogene v-mos is the 
transforming gene of M-MSV [Blair et al., 1984]. 
Since in a preliminary experiment we observed that 
IFN affects the cell cycle distribution of NIH/3T3 
(MSV) cells (data not shown) and because these cells 
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Figure 2 (at left) : Reversibility of the IFN effec t on c ell growth. Cells treated for 72 h with the indicated 
IFN concentrations (IU /ml) were subdivided. One set was further treated with the same IFN concentrations 
(circles), while the other received IFN-free medium (triangles). Cell number (solid lines) and protein synthesis 
(broken lines) were determined at various times after IFN was removed. 
Figure 3 (at right): Reversibility of the IFN-effect on cloning efficiency. Cultures were treated as described 
in Fig. 2. Cells were cloned in IFN - free medium at various times after removal of IFN and the number of 
c lones was scored 10 - 14 days later. Squares - set with no IFN treatment after first 72 h; circles - set 
treated continuously with IFN. 
Figure 4. Reversibility of 
the IF N-effect on 2- 5A-
s y n thetas e activity. 
Cultures were treated as 
described in Fig. 2, at two 
IFN-concentrations, as 
indicated in each column. 
Activity of 2-5A-synthetase 
was determined at various 
times after IFN removal 
and is presented as the 
ratio between the enzy -
matic level detected in 
IFN-treated cells and that 
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Figure 5. Effect of IFN on the expression 
of c -myc and v-mos. Cultures were 
treated with 450 IU /ml of IFN for 24 h. 
Samples containing 1.5 microgram of 
poly (A)+ RNA were then analyzed for the 
presence of either c -myc or v - mos se-
quences (+IFN). The IFN-containing 
medium fer parallel cultures was removerl 
and replaced with fresh IFN-free medium. 
At the indicated times thereafter (-IFN), 
poly (A)+ RNA was isolated and 8 micro-
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Figure 7. Double-stranded RNA activated protein 
kinase activity during myogenesis in rat muscle cul-
tures. Cultures were prepared and analyzed for pro-
tein kinase activity as described in Fig. 6. Inset: 
The appearance of the major phosphorylated protein, 
P68, is demonstrated and its tracing, obtained with a 
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Figure 6. Kinetics of 2-5A-synthetase activity during 
myogenesis in rat. Rat - skeletal muscle cultures were 
prepared, and at daily intervals thereafter, 2-5A-syn -
thetase activity was determined in cell extracts. 
Inset: Appearance of the enzymatic products isolated 
by high voltage electrophoresis. As a marker (right 
column), we used a cell extract prepared from 
NIH/3T3(MSV) cells incubated with 300 IU of mouse 
beta-IFN for 24 h. This extract was analyzed in 
parallel with those of muscle origin [Birnbaum et al, 
1990]. 
are transformed by M-MSV, it was important to 
study the effect of IFN on the expression of these 
genes in our experimental system. We were particu-
larly interested in following the expression after the 
removal of IFN from the culture medium because this 
could provide some clues as to whether IFN acts on 
the expression of these two genes by similar 
mechanism. 
Thus, cultures were treated with IFN for 24 h, 
the medium was then replaced with IFN-free medium 
and the kinetics of both c -myc and v - mos expression 
was determined by slot-blot analysis of poly (A)+-
containing RNA at different times thereafter. The 
results , summarized in Fig. 5, indicate that IFN 
treatment caused complete disappearance of both c -
myc and v-mos transcripts at 24 h after the treat-
ment was initiated. However, following removal of 
IFN, the level of c-myc RNA transcripts increased 
gradually as a function of time. On the other hand, 
the kinetics of v-mos expression under the same 
conditions was different. Although by 24 h after the 
addition of IFN similar results to those observed 
with c-m)C were evident, by 6 h after IFN-removal, 
an increase in the amount of transcripts was clearly 
visible, which was followed by a gradual decrease 
toward the background levels observed in untreated 
cultures (not shown). Under similar conditions no 
alteration in beta-actin gene expression was observed 
before or after IFN removal (Ahwan et al., submitted 
for publication). 
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Activation of the IFN system during myogenesis 
Terminal differentiation is associated with 
growth arrest of the differentiated cells. We showed 
that the level of 2-5A-synthetase activity correlates 
well with the antiproliferative activity of IFN. 
Therefore, it was now important to clarify whether 
the IFN system is also activated during the differ-
entiation process. 
Myoblasts obtained from rat, mouse, or chick 
embryonic muscle provide a unique model for the 
study of differentiation. Within a week after seed-
ing, these cells fuse to form myotubes, which con-
tract spontaneously while synthesizing muscle specific 
proteins. In order to study the involvement of the 
IFN system in myogenesis, rat embryonic muscle cul-
tures were prepared and, at daily intervals after 
seeding, 2-5A-synthetase activity was determined in 
cell extracts. The enzymatic products included the 
various 2 -5A oligomers formed in the assay. These 
were separated by high-voltage electrophoresis, and 
the radioactive spots were identified by autoradio-
graphy. The results are demonstrated in the inset to 
Fig. 6. The scanning analysis of the radioactive 
spots is illustrated in the major section of Fig. 6 
which shows that 2-5A-synthetase activity was tran-
siently elevated during myogenesis. After a low 
basal level on the first day in culture there was a 
gradual increase to a peak activity on the third day 
and a decline on the following days. The major en-
zymatic product detected in muscle cell extracts was 
the trimer form of 2-5A, although traces of the 
dimer form could also be observed. The same result 
was obtained with muscle cell extracts from the 
other animal species used in this study. In contrast, 
a series of oligomers was observed with cell extracts 
prepared from IFN-treated NIH/3T3(MSV) cells which 
served as a marker (Fig. 6 inset, right column). 
Next, we decided to determine the kinetics of 
the activity of double-stranded activated protein 
kinase, a well known and characterized IFN-induced 
protein [ Galabru et al., 1984; Galabru, Hovanessian, 
1985]. Similar kinetics to that observed with 2-5A-
synthetase will support the assumption that several 
proteins known to be induced by IFN are elevated in 
a characteristic manner during the differentiation of 
skeletal muscle cultures. 
Cell extracts were prepared at daily intervals 
after seeding and the protein kinase activity was as-
sayed in each extract. In Fig. 7, the appearance of 
the major phosphorylated protein, P68, most likely 
the enzyme molecule itself [ Galabru, Hovanessian, 
1985], is shown in the inset and its tracing regis-
tered by a scanning densitometer is demonstrated in 
the main part of the figure. Similar to the pattern 
observed with 2-5A-synthetase, the activity of pro-
tein kinase was transiently elevated in rat skeletal 
muscle cultures, reaching a peak activity on the 
third day in culture. 
Discussion 
The mechanism involved in the antiproliferative 
effect of IFN is still not completely understood. 
However, since the antiviral property of IFN appears 
to be mediated through proteins induced in IFN -
treated cells [Baglioni, 1979], it is tempting to pos-
tulate that most biological effects of IF N are also 
mediated through similar sets of proteins. Indeed, 
published data demonstrate a correlation between the 
sensitivity of cell growth to IFN and the inducibility 
of 2-5A-synthetase by IFN in these cells [Czarniecki 
et al., 1981; Kimchi, 1981], although some reports do 
not always support this conclusion [Vandenbussche et 
al.,1981]. 
There is no doubt that various types of cells 
differ in their sensitivity to IFN and in the induci-
bility of 2-5A-synthetase, indicating that IFN acts 
through various mechanisms [Esteban, Paez, 1985]. 
However, in a few cell lines derived from NIH/3T3 
mouse fibroblasts, a defect detected in the 2-5A-sys-
tem was responsible for the resistance of the cells 
to, at least, the IFN-induced antiviral effect [Epstein 
et al., 1981; Salzberg et al., 1983]. We have demon-
strated that a few MSV-transformed mouse fibroblast 
clones possess an unusually high basal level of 2-5A-
synthetase activity. These cells are relatively re -
sistant to cytolytic viral infection even in the ab-
sence of IFN [David et al., 1989). Hence, it seems 
important to establish whether it is possible to attri-
bute an essential role to an IFN-induced enzyme in 
its antiproliferative effect as well. In the present 
study, a correlation between the level of 2-5A-syn-
thetase activity and the antiproliferative effect mani -
fested by IFN on MSV-transformed NIH/3T3 cells was 
demonstrated. IFN strongly inhibited the growth of 
the transformed cells in a dose-dependent manner, 
while 2-5A-synthetase activity was induced to a sig-
nificantly high level under the same experimental 
conditions. Furthermore, we demonstrated for the 
first time that as long as the activity of this enzyme 
is not reduced following the removal of IFN from the 
culture medium (e.e., with 1800 IU /ml), the antipro-
liferative effect of IFN remains constant. However, 
when lower IFN concentrations were used ( 450 IU / 
ml), recovery was clearly observed, and this was ac-
companied by a reduction in 2-5A-synthetase activity. 
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The role of the 2-5A system in the development 
of the antiproliferative effect is not clear. Certain-
ly, 2-5A-synthetase could be just one of a variety of 
factors, including IFN-induced protein kinase 
[ Galabru, Hovanessian, 1985), which may function 
during this process and lead to the regulation of 
gene expression. 
The protooncogene c -myc has been shown to be 
involved in differentiation and growth arrest in 
several cell systems [ Gonda, Metcalf, 1984; Lachman, 
Shoulchi, 1984; Dean et al., 1986; Siebenlist et al., 
1988). During these processes, c-myc expression is 
reduced, apparently by a two-step mechanism leading 
to an initial post-transcriptional block which is 
followed by inhibition of c -myc transcription 
[Siebenlist et al., 1988]. On the other hand, c-myc 
as well as other nuclear protooncogenes are tran-
siently activated when cells are induced to prolifer-
ate [Campisi et al., 1984; Cochran et al., 1984; 
Greenberg et al., 1985; Kelly et al., 1983]. It is, 
thus, obvious that the level of expression of c-myc 
is an indication of the availability of the cell for 
replication. This fact is supported by our data 
which demonstrate that, in NIH/3T3(MSV) cells, IFN-
treatment results in a rapid reduction in the expres-
sion of c-myc. In this respect, these cells behave 
similarly to those of other IFN-sensitive cell lines, 
particularly Daudi cells, which have also shown a 
reduction in c - myc expression following IFN treat-
ment [Einat et al., 1985; Jonak, Knight, 1984; Dani et 
al., 1985). 
V-mos is the transforming oncogene of M-MSV 
S. Salzberg, D. Hacohen, S. David 
[Blair et al., 1984], and its expression is driven by 
the viral promoter present in the viral long terminal 
repeat. Therefore, this expression may be regulated 
by a different mechanism than cellular genes. 
At least two possibilities are immediately feasi-
ble in explaining the mechanism involved in the inhi-
bition of c-myc or v-mos expression by IFN in our 
experimental system. First, a shut-off of the tran-
scription machinery is apparently a target of IFN 
action, as has been shown by Einat and colleagues 
[Einat et al., 1985]. However, a post-transcriptional 
control, which affects the stability of RNA tran-
scripts rather than the transcription rate, must also 
be considered, especially since such a mechanism of 
IF N -action has been reported [Jonak, Knight, 198 4; 
Dani et al., 198 5] . Finally, a more complex mecha-
nism which combines both possibilities cannot be 
ruled out. For example, one can argue that IFN 
first causes pretermination of transcription at the 
non -coding sequence of the first myc axon [ Nepveu, 
Marcu, 1986], and only then a block in the tran-
scription process itself. However, in our experiment-
al system there was a difference in the kinetics of 
reappearance of c -myc and of v-mos transcripts upon 
removal of IFN. In the case of c-myc, a gradual in-
crease in the level of mRNA specific molecules was 
observed, which, we suggest, is an indication of the 
resumption of the transcription activity that is 
blocked in the presence of IFN. However, in the 
case of v-mos, an immediate increase in the level of 
RNA transcripts was evident, followed by a decrease 
toward control levels. One possible explanation for 
this phenomenon is that IFN affects the stability of 
this type of transcript only but does not interfere 
with the binding of DNA polymerase to the gene 
promoter. When the block is removed, mRNA mole-
cules are immediately available in great abundance, 
as active transcription never ceases. This is fol -
lowed by a stabilization step concomitant with the 
reappearance of a regular cell phenotype. 
It has been shown that IFN stimulates various 
morphologic and biochemical changes in several cell 
systems. The best examples studied thus far are the 
hematopoietic cell systems [Rossi et al., 1980; Tomida 
et al., 1982; Fisher et al., 1983; Hattori et al., 1983; 
Harris et al., 1985]. Indeed it has been demonstrated 
that IFN is released in an autocrine fashion in some 
hematopoietic cells induced to differentiate with the 
appropriate agents [Kimchi, 1981; Friedman-Einat et 
al., 1982; Yardenet al., 1984; Resnitzky et al., 1986]. 
This release is reflected by an elevated level of 2-
5A-synthetase activity, an indication that the IFN 
system may be involved in the differentiation proc -
ess , as suggested by Chebath and colleagues (1986]. 
Our results show that the possible involvement 
of the IFN system in the differentiation process is 
not limited to certain hematopoietic cells, but that it 
may have a much wider significance. We have clear-
ly shown that the activity of both 2 -5A-synthetase 
and double-stranded RNA-activated protein kinase in-
crease transiently in muscle primary cell extracts, 
reaching a peak activity at 3 days in culture, at the 
onset of the fusion process. The enzymatic activities 
appear to have similar kinetics in cultures derived 
from three different species (data not shown) and 
seem to precede the appearance of muscle specific 
proteins, particularly in the case of rat-derived cell 
cultures. Although it is certainly possible that this 
similarity in kinetics is coincidental and that these 
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enzymes have no functional role in myogenesis, it is 
reasonable to consider that the IFN system may play 
an important role in the initiation of the differentia-
tion process. This hypothesis is strengthened by the 
fact that the enzymatic product of 2-5A-synthetase 
present in myoblasts is the trimer form of 2-5A, 
which is unique and may reflect an activity of a 
more specialized enzyme. Indeed, various forms of 
2-5A-synthetase have been detected in IFN-treated 
cells [Chebath et al., 1987a]. Another indication of 
the importance of the IFN system is the fact that 
the enzymatic activities of both 2-5A-synthetase and 
protein kinase are reduced to basal levels in fully 
differentiated myotubes, indicating that these en-
zymes are no longer needed at this stage of the dif-
ferentiation process. An identical trimer form of 2-
5A with similar kinetics was observed during chon-
driogenesis in vivo [Maor et al., in preparation]. 
The exact role that the IFN system may fulfill 
during differentiation remains unclear. However, it 
is evident that nuclear protooncogenes, particularly 
c -myc, are essential for cell-growth and are switched 
off during the differentiation of several cell systems, 
including hematopoietic cells [ Gonda, Metcalf, 1984; 
Lachman, Shoulchi, 1984]. In some cases, for exam-
ple in the murine embryonal carcinoma cell line F9 
induced to differentiate with retinoic acid and cyclic 
AMP, the expression of c -myc is regulated post -
transcriptionally [Dean et al., 1986]. One inter-
pretation is that the stability of c -myc mRNA tran -
scripts is reduced in this system, which could cer-
tainly be the result of nuclease activity induced by 
2-5A oligomers, the enzymatic products of 2-5A-
synthetase [Baglioni, 1979]. The reduction in c-myc 
expression has been demonstrated also during differ-
entiation of myoblasts [Olson et al., 1987], and 
therefore a similar mechanism in these cells is 
possible. 
Based on the results of this study, we suggest 
that the IFN system may be involved in the differen-
tiation process of cells of various lineages and may 
indeed be crucial for the normal progression of dif -
ferentiation. An altered expression of the IFN sys-
tem or a lack of response to its signals may there-
fore lead to the development of malignancy. How-
ever, more direct proof is needed before the role of 
the IFN system in myogenesis can be established 
unambiguously. 
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Discussion with Reviewers 
P.M. Grimley: How specifically does your data con-
tribute to a better understanding of the effects of 
interferon on differentiation? For example, the adi-
pocyte model has already been examined in consider-
able detail by Grossberg et al. In view of previous 
data, how can you postulate a significant role of 2-
5A-synthetase, since you did not assay for RNAase 
or ribosomal cleavage activity in your experiments? 
Authors : The discussion brings data that support the 
hypothesis that the activation of the IFN system 
occurs both in IFN-growth arrested cells and during 
terminal differentiation. In both cases, cells enter 
the G0 phase in the cell cycle. It is true that these 
findings are only correlative and may be fortuitous. 
Also, we point out that in different differentiating 
systems like myogenesis or chondriogenesis, the ap -
pearance of 2-5A - synthetase or protein kinase activ -
ities occur in a specific manner. Certainly, only 
when specific inhibitors for 2- 5A - synthetase or anti-
sense RNA will be available, a more direct approach 
c an be utilized. 
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B. Silverman: What is the rationale for adding 
heparm to the protein kinase assays? Hovanessian 
showed that heparin activates the kinase. 
Authors: Heparin inhibits the activity of most 
protem kinases not related to the IFN-effect. 
J. Chebath: Did you determine the levels of c -myc 
and v-mos expression in cells treated for 3 days by 
1800 U/ml of IFN? 
Authors : The recovery of c-myc and v-mos expres-
sion after IFN-removal was studied on cultures 
treated for 24 h only with IFN. We are planning to 
perform a more detailed analysis on the recovery of 
cells treated for extended periods of time with 
different concentrations of IFN. 
J. Chebath: Did you try to identify further the 
radioactive oligomers of ATP formed in the muscle 
cell extracts in the course of differentiation as 
authentic 2-5A trimer? 
Authors: We used two sets of markers for the iden-
tification of the 2-5A oligomers, including authentic 
molecules. We believe that those markers are suffi-
cient to positively identify the enzymatic products , 
particularly when the experiments were performed at 
least 6 times with identical results. 
